egcg enhances the therapeutic potential of gemcitabine and cp690550 by inhibiting stat3 signaling pathway in human pancreatic canceregcg提高吉西他滨的治疗潜力和cp690550通过抑制stat3信号通路在人类胰腺癌.pdfVIP

下载本文档

3
0
约7.42万字
约 11页
2017-09-12 发布于上海
举报

egcg enhances the therapeutic potential of gemcitabine and cp690550 by inhibiting stat3 signaling pathway in human pancreatic canceregcg提高吉西他滨的治疗潜力和cp690550通过抑制stat3信号通路在人类胰腺癌.pdf

egcg enhances the therapeutic potential of gemcitabine and cp690550 by inhibiting stat3 signaling pathway in human pancreatic canceregcg提高吉西他滨的治疗潜力和cp690550通过抑制stat3信号通路在人类胰腺癌

EGCG Enhances the Therapeutic Potential of Gemcitabine and CP690550 by Inhibiting STAT3 Signaling Pathway in Human Pancreatic Cancer 1 2 2 1 Su-Ni Tang , Junsheng Fu , Sharmila Shankar , Rakesh K. Srivastava * 1 Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas, United States of America, 2 Department of Pathology and Laboratory Medicine, The University of Kansa

您可能关注的文档

文档评论（0）

1亿VIP精品文档

更多 >

egcg enhances the therapeutic potential of gemcitabine and cp690550 by inhibiting stat3 signaling pathway in human pancreatic canceregcg提高吉西他滨的治疗潜力和cp690550通过抑制stat3信号通路在人类胰腺癌.pdfVIP